Chief Executive Officer, Co-Founder

Wensheng Fan is a Co-Founder and the first employee of Spectral MD. Over the past 11 years he has served as CTO and COO, before becoming the CEO of Spectral MD. He is an executive, entrepreneur, and innovator with over 20 years of experience in natural speech recognition and imaging systems. Mr. Fan held various leadership roles in strategy, engineering, and operations with Sensata Technologies and Philips. He also has a long history of experience in business development and cross-functional team leadership, being a founder and/or early core member of multiple successful start-up companies. Under his leadership, Spectral MD’s DeepView® was granted FDA Breakthrough Device designation and is well on its way to disrupting the field of healthcare and medical technology.

Mr. Fan received his B.S.E.E. degree from Tsinghua University in Beijing, China and M.S.E.E. degree from Northeastern University in Boston.

Mr. Windler brings more than 20 years of Finance and Operations experience and is recognized as a hands-on, forward-thinking executive and business strategist who leverages extensive financial, operations and sales experience to fuel revenue growth, enhance profitability and seamlessly execute organizational turnarounds and transformations. Prior to joining Spectral MD, Mr. Windler served as Senior Finance Leader and Business Finance Transformation Leader at 3M. Prior to its acquisition, Mr. Windler also served as Vice President of Finance for Americas at KCI, an Acelity company. 

​

Mr. Windler holds an MBA, General Management from The Berlin School of Economics & Law & Anglia Ruskin University in Cambrige, U.K. and a BA, Business Administration, Banking Management, Finance & Investments from The Berlin School of Economics and Law.

Jeffrey Thatcher, PhD serves as the Chief Scientist at Spectral MD. He currently oversees technology and applications research for medical imaging systems. He is a former Howard Hughes Medical Institute (HHMI) undergraduate research fellow, has served as PI on three National Science Foundation (NSF) grants, and is currently the PI of an Health and Human Services Biomedical Advanced Research and Development Authority (HHS/BARDA) government contract to develop an imaging device to assist with burn care. ​

​

Dr. Thatcher received a B.S. in molecular biology from Texas Tech University and Ph.D. in biomedical engineering from University of Texas Southwestern Medical Center.

Kevin Plant leads Software Engineering at Spectral MD. He currently directs the Application Software and Deep Learning Data Science teams, and drives the medical device product development process.  He has spent his career transforming medical research into released medical devices, and specializes in medical device Systems and Software development.  Before Spectral MD, he worked in neuro and cardiac implantable  research and development with St. Jude Medical and Abbott.  

​

Kevin received a B.S. in Biomedical Engineering from the University of Texas at Austin.

Louis Percoco is a seasoned engineering leader who brings more than 31 years of experience to the field of Research, Development, and Production. Louis has spent his career developing and manufacturing Electronics, Software, and Hardware benefiting the Medical Device Industry. Recognized as a thought leader in the field of software and electronic controlled medical devices, Louis has led R&D and Production teams in Cardiology, Orthopedic and Spine disciplines. 

​

​​

Mary Regan, Ph.D. serves as VP Clinical Affairs at Spectral MD where she oversees all clinical trials and supports the commercial business operations. Dr. Regan brings over 30 years of clinical experience in wound technology assessment, development, research, and innovation with major industry leaders. Widely renowned in national and international forums as an industry thought leader in wound care, Dr. Regan’s career has been dedicated to improving prevention and management of chronic wounds and clinical research to improve outcomes for all patients with wounds. Dr. Regan has held board positions in the American Association of Wound Care Specialists and National Wound Healing Society.

​

Dr. Regan received her Masters/B.S Degree in Registered Nursing, Nursing Administration, Nursing Research, and Clinical Nursing from SUNY Upstate Medical University and PH.D. in Nursing Science from the University of Miami.

Christine Marks serves as Vice President of Marketing and Commercialization at Spectral MD and brings successful go-to-market experience to the organization.  She has over 20 years of marketing and commercialization experience launching innovations globally at medical device and technology companies such as BSN Medical, Lohmann & Raucher, and Monarch Medical Technologies.

Mrs. Marks earned her M.B.A. degree from Wake Forest University and her B.S. degree in Marketing from Appalachian State University.

Christine Marks

Vice President, Marketing and

Commercialization

Vince Capone

Vince Capone serves as General Counsel and Corporate Secretary at Spectral MD and brings a wealth of experience to the Company.  He began his career as a CPA at KPMG, LLP before practicing corporate and securities law.  He has over 20 years of broad legal experience, first at Morgan Lewis, LLP, then as a Partner at Reed Smith, LLP and most recently, as General Counsel for a New York-based private equity fund investing in global life sciences and technology companies.  Mr. Capone has an extensive background in representing life science and technology companies and he has a proven track record as a business-focused and results-oriented leader in driving corporate growth and development.

​Mr. Capone earned both his J.D. and M.B.A. degrees from Temple University and his B.S. degree in Accounting from Pennsylvania State University. 

General Counsel and

Corporate Secretary

So-Jin Holohan, Ph.D. leads the UK/EU clinical research at Spectral MD and has extensive R&D experience gained from academia, biotech and healthcare sector where she has dedicated eleven years to clinical research in different disease states and therapies. As a Positron Emission Tomography Mathematical Modeller and Drug R&D Methodologist at GE Healthcare, she gained much commercial experience as a point of contact between the company and clients in a multidisciplinary medical device environment. 

​

Dr Holohan received B.Sc. in Physics from Imperial College London and Ph.D. in Nuclear Medicine from King’s College London.

In the Chief Medical Consultant role, Dr. Carter will be guiding Spectral MD’s clinical direction and ensuring that the company’s technology has a meaningful clinical impact for patients and physicians. Dr. Carter has been practicing burn/trauma medicine for over 12 years and currently serves as the Medical Director for the University Medical Center Burn Center in New Orleans, LA, and on faculty at Louisiana State University Health Sciences Center. 

​

Dr. Carter earned his medical degree from East Tennessee State University in 2005 with honors and practiced general surgery and surgery critical care before specializing in burn treatment. He completed his burn/trauma fellowship at University of North Carolina, Chapel Hill and is board-certified by the American Board of Surgery in Surgery and Surgical Critical Care.